Endogenous adenosine differentially modulates 5-hydroxytryptamine release from a human enterochromaffin cell model

Gastroenterology. 2004 Jul;127(1):188-202. doi: 10.1053/j.gastro.2004.04.070.

Abstract

Background & aims: The aim was to determine whether adenosine receptors modulate cAMP, intracellular free calcium ([Ca(2+)](i)), and 5-hydroxytryptamine (5-HT) release in human carcinoid BON cells.

Methods: Adenosine receptor (R) mRNA, proteins, and function were identified by Western blots, immunofluorescent labeling, Fluo-4/AM [Ca(2+)](i) imaging, and pharmacologic/physiologic techniques.

Results: A1, A2, and A3Rs were present in BON cells and carcinoid tumors. Baseline 5-HT levels increased with adenosine deaminase, activation of A2Rs, and inhibition of A3Rs, whereas A3R activation decreased 5-HT. A2R antagonists or blockade of adenosine reuptake that elevates extracellular adenosine reduced mechanically evoked 5-HT release. In single BON cells, touch elevated [Ca(2+)](i) responses were augmented by adenosine deaminase, A1, and A3R antagonists.

Conclusions: Tonic or mechanically evoked release of endogenous adenosine is a critical determinant of differential activation of adenosine receptors and may have important implications for gut mechanosensory reflexes.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenosine / physiology*
  • Calcium / metabolism
  • Carcinoid Tumor / metabolism
  • Cell Line, Tumor
  • Cyclic AMP / metabolism
  • Enterochromaffin Cells / metabolism*
  • Humans
  • Mechanotransduction, Cellular / physiology
  • Receptors, Purinergic P1 / metabolism*
  • Serotonin / metabolism*
  • Signal Transduction / physiology

Substances

  • Receptors, Purinergic P1
  • Serotonin
  • Cyclic AMP
  • Adenosine
  • Calcium